Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

3 Reasons These Stocks Make a Brilliant Combination

Published 2018-12-15, 10:38 a/m
Updated 2018-12-15, 11:16 a/m
3 Reasons These Stocks Make a Brilliant Combination

These two stocks make a great one-two punch: the century-old Sun Life Financial Inc (TSX:SLF)(NYSE:SLF) and a younger, growth-oriented software company, Kinaxis Inc (TSX:KXS). Here are three reasons why they work well in a portfolio.

Low correlation of assets Correlation of holdings is important under any market conditions. During the 2008 Financial Crisis, highly correlated assets tumbled in unison. Financial stocks fell hard and Sun Life was no exception as over 50% of the share price was wiped out in just 8 months.

Defensive stocks like grocer Metro Inc (TSX:MRU) actually rallied over 200% starting around the time of the Financial Crisis in 2014. Although recessions are cyclical, the underlying drivers are often different each time. If we are due, as pundits lead us to believe, then it is not likely to be caused by dubious lending practices again. Sun Life should hold up. Besides, shares have already been dropping, down 14% over the year.

Kinaxis has not been subjected to a major market stress test, as this software-as-a-service company doesn’t have a public trading record that goes back to the last recession. No stock is immune to a potential deep cut. Reliance on automotive and electronic sectors could be a vulnerability for Kinaxis’ supply chain solutions, although the client base is very broad to help weather sector-specific storms.

A tale of two betas Compared to four other insurance stocks, Sun Life has lower volatility, as reflected by a low beta. This means that Sun Life shares are more tempered during market-wide swings. When it comes to price volatility, Kinaxis can move around tremendously, as much as 3% within one day is not out of the ordinary. Ironically, relative to its sector, Kinaxis also has a pretty reasonable beta. It’s fair to say that both Sun Life and Kinaxis beat to their own drum, which gets back to the previous point on assets more immune to market swings.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

One income, one growth Sun Life has increased the dividend as far back as the company investor relations website provides. During an 18-year run, the annual increase was 8.25% and the current yield corresponds to quarterly cash distributions of $0.50 per share. Owning 100 shares of Sun Life would produce $200 from the dividend in year one.

That may not sound like a lot, but if you hold this income producing stock for 10 years, the cumulative dividend cash should amount to just under $3000 of passive income. A few years beyond a decade and that initial investment amount of $4500 would be double from the dividend alone.

Whereas, Kinaxis will continue to provide growth without dividend income. The fast-moving business has no dividend mandate, and that will likely remain the case. I for one am perfectly fine with this. In fact, it would be odd to see an innovative company pouring money into a dividend program.

Ambrose O’Callaghan picked Kinaxis as a top pick for June and December. I’m also impressed, particularly with the subscription revenue that grew 19% organically in the last quarter. Growth stocks are all getting racked with any signs of weakness. Kinaxis reported some delays in business deals, which is enough of a concern to precipitate a >20% drop in share price. If anything, the price drop has helped reel in the lofty price-to-earnings ratio.

Foolish takeaway

Sun Life and Kinaxis are at opposite ends of the valuation spectrum. They will also provide overall return through nearly opposite means. But in this case, opposites attract. Given time, both should double in value; it’s just a question of how and when.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Fool contributor Brad Macintosh owns shares of KINAXIS INC and SUN LIFE FINANCIAL INC. Kinaxis is a recommendation of Stock Advisor Canada.

This Article Was First Published on The Motley Fool

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.